Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: An immunohistochemical and clinical correlation analysis

Medical Oncology

Volumn 31, Issue 8, 2014, Pages

  Ren, Wen Hao ^a   Zhang, Lin Mei ^a   Liu, Huai Qin ^b   Gao, Ling ^a   Chen, Cheng ^a   Qiang, Cui ^a   Wang, Xiao Long ^a   Liu, Chang Yang ^a   Li, Shao Ming ^a   Huang, Chen ^a   Qi, Hong ^a   Zhi, Ke Qian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b First Hospital of Yulin   (China)

Author keywords

CIRP; IHC; OSCC; Prognosis; TLR4

Indexed keywords

TOLL LIKE RECEPTOR 4; CIRBP PROTEIN, HUMAN; RNA BINDING PROTEIN; TLR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; COLD INDUCIBLE RNA BINDING GENE; CONTROLLED STUDY; FEMALE; GENE; GENE CONTROL; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SURVIVAL RATE; TOLL LIKE RECEPTOR 4 GENE; METABOLISM; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROCEDURES; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RNA-BINDING PROTEINS; SURVIVAL RATE; TOLL-LIKE RECEPTOR 4; TUMOR MARKERS, BIOLOGICAL;

EID: 84904226373     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0120-7     Document Type: Article

References (31)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46(1):5-27. (Pubitemid 26043582)
2. Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, et al. SEER cancer statistics review, 1975-2005. Bethesda: National Cancer Institute; 2008. p. 1975-2005.
3. Chen R, Alvero AB, Silasi DA, Mor G. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol. 2007;57(2):93-107. (Pubitemid 46099804)
4. Qiang X, Yang W-L, Wu R, Zhou M, Jacob A, Dong W, et al. Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat Med. 2013;19(11):1489-95.
5. Nishiyama H, Itoh K, Kaneko Y, KishishitaM, Yoshida O, Fujita J. A glycine-rich RNA-binding protein mediating cold-inducible suppression of mammalian cell growth. J Cell Biol. 1997;137(4):899-908. (Pubitemid 27215512)
6. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9(10):1149-63.
7. Sakurai T, Itoh K, Higashitsuji H, Nonoguchi K, Liu Y, Watanabe H, et al. Cirp protects against tumor necrosis factor-α-induced apoptosis via activation of extracellular signal-regulated kinase. Biochim Biophys Acta (BBA)-Mol Cell Res. 2006;1763(3):290-5.
8. Guo X, Wu Y, Hartley RS. Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer. Mol Carcinog. 2010;49(2):130-40.
9. Nishiyama H, Higashitsuji H, Yokoi H, Itoh K, Danno S, Matsuda T, et al. Cloning and characterization of human CIRP (cold-inducible RNA-binding protein) cDNA and chromosomal assignment of the gene. Gene. 1997;204(1):115-20. (Pubitemid 28022177)
10. Nishiyama H, Danno S, Kaneko Y, Itoh K, Yokoi H, Fukumoto M, et al. Decreased expression of cold-inducible RNA-binding protein (CIRP) in male germ cells at elevated temperature. Am J Pathol. 1998;152(1):289.
11. Nishiyama H, Xue J-H, Sato T, Fukuyama H, Mizuno N, Houtani T, et al. Diurnal change of the cold-inducible RNA-binding protein (Cirp) expression in mouse brain. Biochem Biophys Res Commun. 1998;245(2):534-8. (Pubitemid 28418540)
12. 2 on the cold stress protein CIRP expression in rat neuronal cells. Free Radic Biol Med. 1999;27(11):1238-44.
13. Sheikh MS, Carrier F, Papathanasiou MA, Hollander MC, Zhan Q, Yu K, et al. Identification of several human homologs of hamster DNA damage-inducible transcripts cloning and characterization of a novel uv-inducible cDNA that codes for a putative RNA-binding protein. J Biol Chem. 1997;272(42):26720-6. (Pubitemid 27458899)
14. Wellmann S, Bührer C, Moderegger E, Zelmer A, Kirschner R, Koehne P, et al. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci. 2004;117(9):1785-94. (Pubitemid 38559310)
15. Park JS, Svetkauskaite D, He Q, Kim J-Y, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370-7. (Pubitemid 38294612)
16. Ohashi K, Burkart V, Flohé S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164(2):558-61. (Pubitemid 30043672)
17. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195(1):99-111. (Pubitemid 34074500)
18. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates toll-like receptor 4. J Biol Chem. 2001;276(13):10229-33.
19. Benhamou Y, Favre J, Musette P, Renet S, Thuillez C, Richard V, et al. Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Crit Care Med. 2009;37(5):1724-8.
20. Wittebole X, Castanares-Zapatero D, Laterre PF. Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm. 2010. doi:10.1155/2010/568396.
21. Nishiyama H, Higashitsuji H, Yokoi H, Itoh K, Danno S, Matsuda T, et al. Cloning and characterization of human CIRP (cold-inducible RNA-binding protein) cDNA and chromosomal assignment of the gene. Gene. 1997;204(1-2):115-20. (Pubitemid 28022177)
22. Zeng Y, Kulkarni P, Inoue T, Getzenberg RH. Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity. J Cell Biochem. 2009;107(1):179-88. doi:10.1002/jcb.22114.
23. Hamid AA, Mandai M, Fujita J, Nanbu K, Kariya M, Kusakari T, et al. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Pathol. 2003;22(3):240-7. doi:10.1097/01.pgp.0000070851.25718.ec. (Pubitemid 36750405)
24. Artero-Castro A, Callejas FB, Castellvi J, Kondoh H, Carnero A, Fernandez-Marcos PJ, et al. Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation. Mol Cell Biol. 2009;29(7):1855-68. doi:10.1128/mcb.01386-08.
25. He W, Liu Q, Wang L, Chen W, Li N, Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol. 2007;44(11):2850-9. doi:10.1016/j.molimm. 2007.01.022. (Pubitemid 46412506)
26. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006;66(7):3859-68. doi:10.1158/0008-5472.can-05-3948.
27. Molteni M, Marabella D, Orlandi C, Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett. 2006;235(1):75-83. doi:10.1016/j.canlet.2005.04.006.
28. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, et al. Triggering of toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res. 2009;69(7):3105-13. doi:10.1158/0008-5472.can-08-3838.
29. Kamada M, So A, Muramaki M, Rocchi P, Beraldi E, Gleave M. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol Cancer Ther. 2007;6(1):299-308. (Pubitemid 46206694)
30. Sakurai T, Itoh K, Higashitsuji H, Nonoguchi K, Liu Y, Watanabe H, et al. Cirp protects against tumor necrosis factor-alphainduced apoptosis via activation of extracellular signal-regulated kinase. Biochim Biophys Acta. 2006;1763(3):290-5. doi:10.1016/j.bbamcr.2006.02.007.
31. Wang AC, Su QB, Wu FX, Zhang XL, Liu PS. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur J Clin Invest. 2009;39(2):157-64. doi:10.1111/j.1365-2362.2008.02070.x.